Procaps Group, S.A Retained Earnings (Accumulated Deficit) 2020-2023 | PROCF

Procaps Group, S.A retained earnings (accumulated deficit) from 2020 to 2023. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Procaps Group, S.A Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2022 $-392
2021 $-431
2020 $-327
2020 $-13
2019 $
2019 $-0
2018 $-0
Procaps Group, S.A Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023-09-30 $-354
2023-06-30 $-362
2023-03-31 $-385
2022-12-31 $-392
2022-09-30 $-402
2022-06-30 $-425
2022-03-31 $-418
2021-12-31 $-431
2021-09-30
2021-06-30 $-29
2021-03-31 $-23
2020-12-31 $-327
2020-09-30 $-13
2020-06-30 $1
2020-03-31 $1
2019-12-31 $0
2019-09-30 $-0
2019-06-30
2019-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.125B $0.410B
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Stock Name Country Market Cap PE Ratio
NextEra Energy Partners, LP (XIFR) United States $0.828B 4.49